Wikidata

(Q61933940)

English

Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer

clinical trial

In more languages

Statements

title
Phase I Study Investigating the Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer With High and Moderate HER2 Expression (English)
0 references
country
Austria
0 references
start time
July 2006
0 references
end time
June 2011
0 references
number of participants
32
0 references
research intervention
trastuzumab
0 references
cetuximab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61933940&oldid=2170303347"